Malnutrition and Neurodegenerative Diseases

被引:1
作者
Sheard J.M. [1 ]
机构
[1] Chattanooga, TN, 37415
关键词
Alzheimer's disease; Depression; Disease severity; Malnutrition; Malnutrition Screening Tool; Mini-Nutritional Assessment; Nutrition assessment; Nutrition screening; Nutritional status; Parkinson disease; Subjective Global Assessment; Weight loss;
D O I
10.1007/s13668-014-0078-2
中图分类号
学科分类号
摘要
With the aging population, the prevalence of the two most common neurodegenerative disorders, namely Parkinson's disease and Alzheimer's disease, is likely to increase. Given the presence of disease symptoms that are also risk factors for poor nutritional status, weight loss and malnutrition are commonly reported as issues. However, a consensus has not been reached regarding the prevalence and significance of poor nutritional status. Using validated nutrition screening and assessment tools, 14.1-55.9% and 0-12.6% of people with mild Alzheimer's disease are at risk of malnutrition and malnourishment, respectively, while 17.2-23.5% and 0-40% of people with mild to severe Parkinson's disease are at risk of malnutrition and malnourishment, respectively. Disease-specific factors are predictive of nutritional status, and greater disease severity is particularly important. Nutrition intervention data are lacking, but needed, for both diseases. Nutrition screening should occur early in the disease by health professionals with regular patient contact. © 2014 Springer Science+Business Media New York.
引用
收藏
页码:102 / 109
页数:7
相关论文
共 50 条
  • [41] Synapses in neurodegenerative diseases
    Bae, Jae Ryul
    Kim, Sung Hyun
    BMB REPORTS, 2017, 50 (05) : 237 - 246
  • [42] Minocycline and neurodegenerative diseases
    Kim, Hye-Sun
    Suh, Yoo-Hun
    BEHAVIOURAL BRAIN RESEARCH, 2009, 196 (02) : 168 - 179
  • [43] microRNAs and Neurodegenerative Diseases
    Qiu, Lifeng
    Tan, Eng King
    Zeng, Li
    MICRORNA: MEDICAL EVIDENCE: FROM MOLECULAR BIOLOGY TO CLINICAL PRACTICE, 2015, 888 : 85 - 105
  • [44] Proteasome and Neurodegenerative Diseases
    Catalgol, Betul
    Grune, Tilman
    PROTEASOMAL SYSTEM IN AGING AND DISEASE, 2012, 109 : 397 - 414
  • [45] Oxysterols and neurodegenerative diseases
    Bjorkhem, Ingemar
    Cedazo-Minguez, Angel
    Leoni, Valerio
    Meaney, Steve
    MOLECULAR ASPECTS OF MEDICINE, 2009, 30 (03) : 171 - 179
  • [46] Metabolomics of Neurodegenerative Diseases
    Botas, Alejandro
    Campbell, Hannah Moore
    Han, Xu
    Maletic-Savatic, Mirjana
    OMIC STUDIES OF NEURODEGENERATIVE DISEASE, PT B, 2015, 122 : 53 - 80
  • [47] Zeolite and Neurodegenerative Diseases
    Panaiotov, Stefan
    Tancheva, Lyubka
    Kalfin, Reni
    Petkova-Kirova, Polina
    MOLECULES, 2024, 29 (11):
  • [48] Inflammation in neurodegenerative diseases
    Amor, Sandra
    Puentes, Fabiola
    Baker, David
    van der Valk, Paul
    IMMUNOLOGY, 2010, 129 (02) : 154 - 169
  • [49] CSPα in neurodegenerative diseases
    Huang, Liqin
    Zhang, Zhaohui
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [50] The microbiome and neurodegenerative diseases
    Frahm, C.
    Witte, O. W.
    GASTROENTEROLOGE, 2019, 14 (03): : 166 - 171